Arcturus Therapeutics Holdings, Inc. (ARCT)
7.125
-0.18
(-2.40%)
USD |
NASDAQ |
Jun 08, 16:00
7.125
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings EPS Diluted (Quarterly) : -0.9487 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Oncotelic Therapeutics, Inc. | -0.0049 |
| Enanta Pharmaceuticals, Inc. | -0.4508 |
| Veracyte, Inc. | 0.353 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.96M |
| Revenue (Quarterly) | 0.61M |
| Total Expenses (Quarterly) | 27.57M |
| Enterprise Value | 20.10M |
| Gross Profit Margin (Quarterly) | -7.87% |
| Profit Margin (Quarterly) | -4.42K% |
| Earnings Yield | -39.52% |
| Normalized Earnings Yield | -35.62 |